A commitment to research, safety and quality are some of the many reasons our patients report a better quality of life. Our research results in effective and quality care which has led to the development of new therapies, medications and vaccines, including the HPV vaccine — the first vaccine to prevent gynecologic cancer. Our patient satisfaction scores are among the highest in the nation, due to our commitment to safety and quality.
Patients benefit from access to the advanced treatments created at Johns Hopkins. Our clinical trials are scientific studies that advance cancer care and prove the effectiveness of a new medication or procedure, allowing people with cancer to live longer, fuller lives. Every treatment widely available today used to be part of a clinical trial.
Want to learn more about clinical trials at Hopkins? We break down the details and why it’s important to participate—for yourself and the community at our understanding clinical trials page.
National Cancer Institute SPORE
Johns Hopkins is the recipient of grants from the National Cancer Institute’s Specialized Programs of Research Excellence (SPORE) for ovarian and cervical cancers. Our researchers are helping the world understand more about the cause, development and treatment of gynecologic malignancies.
The Break Through Cancer Project
Johns Hopkins doctors are teaming up with doctors and researchers from other institutions to investigate a breakthrough in preventing ovarian cancer. A common precursor could be the start of intercepting cancer in its tracks.
(Note: You are being directed to an external website for informational purposes only. Johns Hopkins is not responsible for any aspect of the external website.)
Patient Quality and Satisfaction
The Kelly Gynecologic Oncology Service and the Department of Gynecology and Obstetrics’ patient satisfaction scores rank among the highest in the nation. We hold ourselves to a higher standard of care to ensure the utmost in safety and quality for our patients.